GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (FRA:5FA) » Definitions » E10

Nipro (FRA:5FA) E10 : €0.33 (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nipro E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Nipro's adjusted earnings per share data for the three months ended in Sep. 2024 was €-0.086. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.33 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Nipro's average E10 Growth Rate was -3.60% per year. During the past 3 years, the average E10 Growth Rate was 5.10% per year. During the past 5 years, the average E10 Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Nipro was 6.00% per year. The lowest was -3.60% per year. And the median was 1.70% per year.

As of today (2025-03-04), Nipro's current stock price is €8.30. Nipro's E10 for the quarter that ended in Sep. 2024 was €0.33. Nipro's Shiller PE Ratio of today is 25.15.

During the past 13 years, the highest Shiller PE Ratio of Nipro was 66.72. The lowest was 16.55. And the median was 22.24.


Nipro E10 Historical Data

The historical data trend for Nipro's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro E10 Chart

Nipro Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.38 0.40 0.36 0.34

Nipro Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.34 0.34 0.33 -

Competitive Comparison of Nipro's E10

For the Medical Instruments & Supplies subindustry, Nipro's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nipro's Shiller PE Ratio falls into.



Nipro E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nipro's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.086/108.9000*108.9000
=-0.086

Current CPI (Sep. 2024) = 108.9000.

Nipro Quarterly Data

per share eps CPI Adj_EPS
201412 0.400 97.900 0.445
201503 -0.113 97.900 -0.126
201506 0.166 98.400 0.184
201509 0.076 98.500 0.084
201512 0.370 98.100 0.411
201603 0.269 97.900 0.299
201606 0.010 98.100 0.011
201609 0.127 98.000 0.141
201612 0.491 98.400 0.543
201703 -0.132 98.100 -0.147
201706 0.186 98.500 0.206
201709 0.167 98.800 0.184
201712 0.226 99.400 0.248
201803 -0.092 99.200 -0.101
201806 0.198 99.200 0.217
201809 0.123 99.900 0.134
201812 0.098 99.700 0.107
201903 0.101 99.700 0.110
201906 0.127 99.800 0.139
201909 0.145 100.100 0.158
201912 0.228 100.500 0.247
202003 -1.193 100.300 -1.295
202006 0.139 99.900 0.152
202009 0.109 99.900 0.119
202012 0.215 99.300 0.236
202103 0.182 99.900 0.198
202106 0.153 99.500 0.167
202109 0.189 100.100 0.206
202112 0.156 100.100 0.170
202203 0.097 101.100 0.104
202206 0.202 101.800 0.216
202209 0.037 103.100 0.039
202212 0.027 104.100 0.028
202303 -0.102 104.400 -0.106
202306 0.145 105.200 0.150
202309 0.201 106.200 0.206
202312 0.093 106.800 0.095
202403 -0.057 107.200 -0.058
202406 0.084 108.200 0.085
202409 -0.086 108.900 -0.086

Add all the adjusted EPS together and divide 10 will get our e10.


Nipro  (FRA:5FA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Nipro's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=8.30/0.33
=25.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Nipro was 66.72. The lowest was 16.55. And the median was 22.24.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Nipro E10 Related Terms

Thank you for viewing the detailed overview of Nipro's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Nipro Business Description

Traded in Other Exchanges
Address
3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro Headlines

No Headlines